The U.S. Food and Drug Administration (FDA) approved Sevenfact (coagulation factor VIIa [recombinant]-jncw) for the treatment and control of…
Articles by Joana Carvalho, PhD
Ixinity remains readily available to treat people with hemophilia B despite the current COVID-19 outbreak, Medexus…
Poor joint health is associated with a higher risk of low self-esteem in adolescents with hemophilia, a study has…
Prophylactic, or preventive, use of Hemlibra (emicizumab) promotes joint health in people with hemophilia A, according to a new…
A single infusion of AMT-061 (etranacogene dezaparvovec), uniQure’s experimental gene therapy for the treatment of…
Hemophilia News Today brought you daily coverage of important discoveries, treatment developments, clinical trials, and other key events related…
BioMarin Pharmaceuticals is seeking marketing approval in Europe for its investigational gene therapy, valoctocogene roxaparvovec, for the treatment of…
The Analysis Group has partnered with China’s Institute of Hematology & Blood Diseases Hospital (IHBDH) to create the first blood disease…
Direct‐acting antiviral (DAA) therapy is especially effective at eliminating hepatitis C virus (HCV) in people with bleeding disorders,…
Novo Nordisk has entered into a collaboration agreement with Bluebird Bio to develop new therapies based on…